Antengene recently announced the approval of XPOVIO® in Macau for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML). According…
Antengene recently announced the approval of XPOVIO® in Macau for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML). According…
Login below or Register Now.
Already registered? Login.